Indications - Temporary relief of the signs and symptoms of allergic conjunctivitis including conjunctival hyperaemia, chemosis and itching in adults and children above 2 years of age.
Dosage & Administration - Adults and adolescents: 1 drop 2 to 3 times daily upto 14 days. Children Colder than 2 years of age): No specific studies are available in this patient group. For possible systemic effects, the dosage should exceed to 1 to 2 drops per day. Not to be used in children below 2 years of age. The eye drop should not be used for longer periods than 14 days as this may cause rebound hyperaemia and toxic follicular conjunctivitis.
Side Effects - The most common adverse effect is burning/stinging upon installation, which is mild and transient in nature.
Contraindications - Known hypersensitivity to Antazoline/ Tetryzoline or to any of the excipients. Concomitant use with Monoamine Oxidase Inhibitors (MAOI).
Others - Pregnancy & Lactation: Use in Pregnancy: No clinical data on exposed pregnancies are available. The eye drops should only be used if the potential benefits outweigh the risks to the fetus or infant. Use In Lactation: It is not known whether the either of the active substances of the eye drop passes into breast milk. Caution should be exercised when using the product during breast-feeding.